Abstract:The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system, an RNA-guided nuclease for specific genome editing in vivo, has been adopted in a wide variety of organisms. In contrast, the in vitro application of the CRISPR/Cas9 system has rarely been reported. We present here a highly efficient in vitro CRISPR/Cas9-mediated editing (ICE) system that allows specific refactoring of biosynthetic gene clusters in Streptomyces bacteria and other large DNA fragments. Cleavage by Cas9 of circular pUC18 DNA was investigated here as a simple model, revealing that the 3'→5' exonuclease activity of Cas9 generates errors with 5 to 14 nucleotides (nt) randomly missing at the editing joint. T4 DNA polymerase was then used to repair the Cas9-generated sticky ends, giving substantial improvement in editing accuracy. Plasmid pYH285 and cosmid 10A3, harboring a complete biosynthetic gene cluster for the antibiotics RK-682 and holomycin, respectively, were subjected to the ICE system to delete the rkD and homE genes in frame. Specific insertion of the ampicillin resistance gene (bla) into pYH285 was also successfully performed. These results reveal the ICE system to be a rapid, seamless, and highly efficient way to edit DNA fragments, and a powerful new tool for investigating and engineering biosynthetic gene clusters. Importance: Recent improvements in cloning strategies for biosynthetic gene clusters promise rapid advances in understanding and exploiting natural products in the environment. For manipulation of such biosynthetic gene clusters to generate valuable bioactive compounds, efficient and specific gene editing of these large DNA fragments is required. In this study, a highly efficient in vitro DNA editing system has been established. When combined with end repair using T4 DNA polymerase, Cas9 precisely and seamlessly catalyzes targeted editing, including in-frame deletion or insertion of the gene(s) of interest. This in vitro CRISPR editing (ICE) system promises a step forward in our ability to engineer biosynthetic pathways.

Utilizing the CRISPR‐Cas System to Excise and Study the Insulin Enhancer

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Target residence of Cas9: challenges and opportunities in genome editing

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing

CRISPER/CAS: A potential tool for genomes editing

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

CRISPR RNA-guided autonomous delivery of Cas9

In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing

Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR Technology

Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing

An enhanced CRISPR repressor for targeted mammalian gene regulation

CRISPR/Cas9‐Directed Genome Editing of Cultured Cells

Abstract 5607: A highly efficient donor system for CRISPR knock-in editing

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a)

The discovery and development of Cas12A

Synergistic effect of split DNA activators of Cas12a with exon-unwinding and induced targeting effect

A Novel CRISPR Interference Effector Enabling Functional Gene Characterization with Synthetic Guide RNAs

Supramolecular Nanosubstrate‐Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion